Bone mineral density changes in protease inhibitor-sparing vs. nucleoside reverse transcriptase inhibitor-sparing highly active antiretroviral therapy: data from a randomized trial
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
The aim of the study was to compare changes in bone mineral density (BMD) over 144 weeks in HIV-infected patients initiating nucleoside reverse transcriptase inhibitor (NRTI)-sparing or protease inhibitor-sparing highly active antiretroviral therapy (HAART).
Originalsprog | Engelsk |
---|---|
Tidsskrift | HIV Medicine |
Vol/bind | 12 |
Udgave nummer | 3 |
Sider (fra-til) | 157-65 |
Antal sider | 9 |
ISSN | 1464-2662 |
DOI | |
Status | Udgivet - 1 mar. 2011 |
ID: 40155059